Models for institutional and professional accreditation of haemophilia centres in Italy

被引:6
作者
Calizzani, G. [1 ]
Vaglio, S. [1 ]
Arcieri, R. [2 ]
Menichini, I. [2 ]
Tagliaferri, A.
Antoncecchi, S.
Carloni, M. T.
Breda, A.
Santagostino, E.
Ghirardini, A. [3 ]
Tamburrini, M. R. [3 ]
Morfini, M. [4 ]
Mannucci, P. M. [5 ,6 ]
Grazzini, G. [1 ]
机构
[1] Italian Natl Blood Ctr INBC, Rome, Italy
[2] Italian Federat Haemophilia Soc FedEmo, Rome, Italy
[3] Minist Hlth, Rome, Italy
[4] Italian Assoc Haemophilia Ctr Directors AICE, Florence, Italy
[5] IRCCS Maggiore Policlin Hosp, Italian Assoc Haemophilia Ctr Directors AICE, Milan, Italy
[6] IRCCS Maggiore Policlin Hosp, Sci Direct, Milan, Italy
关键词
accreditation; haemophilia; haemophilia centres; recommendations; requirements; standards; QUALITY-OF-LIFE; THERAPY; PREVALENCE; DISORDERS; WORLD; CARE;
D O I
10.1111/hae.12141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Health Commission of the Conference between the Italian State and Regions recognized the need to establish an institutional accreditation model for Haemophilia Centres (HCs) to be implemented by 21 Regions in order to provide patients with haemophilia and allied inherited coagulations disorders with high and uniform standards of care. The Italian National Blood Centre, on behalf of the Commission, convened a panel of clinicians, patients, experts, representatives from Regions and Ministry of Health. The agreed methodology included: systematic literature review and best practice collection, analysis of provisions and regulations of currently avalable services, priority setting, definition of principles and criteria for the development of recommendations on the optimal requirements for HCs. The result was the formulation of two recommendations sets. Two sets of recommendations were produced. The first concerns regional policy planning, in which the following aspects of comprehensive haemophilia care should be considered for implementation: monitoring and auditing, multidisciplinary approach to clinical care, protocols for emergency management, home treatment and its monitoring, patient registries, drug availability and procurement, recruitment and training of health care professionals. The second set concerns the accreditation process and lists 23 organizational requirements for level 1 HCs and 4 additional requirements for level 2 HCs. These recommendations help to provide Italian Regional Health Authorities with an organizational framework for the provision of comprehensive care to patients with inherited coagulation disorders based on current scientific evidence.
引用
收藏
页码:e248 / e255
页数:8
相关论文
共 50 条
  • [21] Thrombin generation testing in haemophilia comprehensive care centres
    Dargaud, Y.
    Negrier, C.
    HAEMOPHILIA, 2010, 16 (02) : 223 - 230
  • [22] Methodological Considerations in the Professional Accreditation Research
    Ayaya, Onesmus
    Pretorius, Marius
    SAGE OPEN, 2021, 11 (04):
  • [23] Professional involvement in the design of accreditation manuals
    Reyes-Alcazar, Victor
    Sotillos-Gonzalez, Belen
    Valverde, Jose A.
    Torres-Olivera, Antonio
    INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2011, 24 (08) : 611 - 620
  • [24] Accreditation of a forensic genetics laboratory in Italy
    Ricci, U.
    De Sanzo, C.
    Carboni, I.
    Iozzi, S.
    Nutini, A. L.
    Torricelli, F.
    FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES, 2013, 4 (01) : E294 - E295
  • [25] Mental health services accreditation in Italy
    Gigantesco, Antonella
    Morosini, Pierluigi
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2010, 16 (06) : 1157 - 1163
  • [26] Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres
    Virginie Nerich
    Edgar Tissot
    Albert Faradji
    Karine Demesmay
    Marie Anne Bertrand
    Jean-Louis Lorenzini
    Marie-Elisabeth Briquel
    Patricia Pouzol
    Marie-Christine Woronoff-Lemsi
    Pharmacy World & Science, 2008, 30 : 287 - 292
  • [27] Bone density in haemophilia: a single institutional cross-sectional study
    Kempton, C. L.
    Antun, A.
    Antoniucci, D. M.
    Carpenter, W.
    Ribeiro, M.
    Stein, S.
    Slovensky, L.
    Elon, L.
    HAEMOPHILIA, 2014, 20 (01) : 121 - 128
  • [28] Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres
    Nerich, Virginie
    Tissot, Edgar
    Faradji, Albert
    Demesmay, Karine
    Bertrand, Marie Anne
    Lorenzini, Jean-Louis
    Briquel, Marie-Elisabeth
    Pouzol, Patricia
    Woronoff-Lemsi, Marie-Christine
    PHARMACY WORLD & SCIENCE, 2008, 30 (03): : 287 - 292
  • [29] Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres
    Gautier, Philippe
    Guillet, Benoit
    Sigaud, Marianne
    Claeyssens, Segolene
    Volot, Fabienne Genre
    Chamouni, Pierre
    Lienahrt, Anne
    Frotscher, Birgit
    Fournel, Alexandra
    Castet, Sabine
    Poumayou, Catherine
    Gay, Valerie
    Thuret, Rodolphe
    Wibaut, Benedicte
    Biron-Andreani, Christine
    HAEMOPHILIA, 2022, 28 (03) : 437 - 444
  • [30] Care models in the management of haemophilia: a systematic review
    Yeung, C. H. T.
    Santesso, N.
    Pai, M.
    Kessler, C.
    Key, N. S.
    Makris, M.
    Navarro-Ruan, T.
    Soucie, J. M.
    Schunemann, H. J.
    Iorio, A.
    HAEMOPHILIA, 2016, 22 : 31 - 40